Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Chronic Infection Depletes Hematopoietic Stem Cells through Stress-Induced Terminal Differentiation.

Matatall KA, Jeong M, Chen S, Sun D, Chen F, Mo Q, Kimmel M, King KY.

Cell Rep. 2016 Dec 6;17(10):2584-2595. doi: 10.1016/j.celrep.2016.11.031.

2.

Overexpression of Semaphorin-3E enhances pancreatic cancer cell growth and associates with poor patient survival.

Yong LK, Lai S, Liang Z, Poteet E, Chen F, van Buren G, Fisher W, Mo Q, Chen C, Yao Q.

Oncotarget. 2016 Dec 27;7(52):87431-87448. doi: 10.18632/oncotarget.13704.

3.

Positive association of collagen type I with non-muscle invasive bladder cancer progression.

Brooks M, Mo Q, Krasnow R, Ho PL, Lee YC, Xiao J, Kurtova A, Lerner S, Godoy G, Jian W, Castro P, Chen F, Rowley D, Ittmann M, Chan KS.

Oncotarget. 2016 Dec 13;7(50):82609-82619. doi: 10.18632/oncotarget.12089.

4.

Erratum: Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation.

Welte T, Kim IS, Tian L, Gao X, Wang H, Li J, Holdman XB, Herschkowitz JI, Pond A, Xie G, Kurley S, Nguyen T, Liao L, Dobrolecki LE, Pang L, Mo Q, Edwards DP, Huang S, Xin L, Xu J, Li Y, Lewis MT, Wang T, Westbrook TF, Rosen JM, Zhang XH.

Nat Cell Biol. 2016 Jun 28;18(7):822. doi: 10.1038/ncb3379. No abstract available.

PMID:
27350446
5.

Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation.

Welte T, Kim IS, Tian L, Gao X, Wang H, Li J, Holdman XB, Herschkowitz JI, Pond A, Xie G, Kurley S, Nguyen T, Liao L, Dobrolecki LE, Pang L, Mo Q, Edwards DP, Huang S, Xin L, Xu J, Li Y, Lewis MT, Wang T, Westbrook TF, Rosen JM, Zhang XH.

Nat Cell Biol. 2016 Jun;18(6):632-44. doi: 10.1038/ncb3355.

6.

CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo.

Tian G, Courtney AN, Jena B, Heczey A, Liu D, Marinova E, Guo L, Xu X, Torikai H, Mo Q, Dotti G, Cooper LJ, Metelitsa LS.

J Clin Invest. 2016 Jun 1;126(6):2341-55. doi: 10.1172/JCI83476.

7.

Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma.

Bharadwaj U, Eckols TK, Xu X, Kasembeli MM, Chen Y, Adachi M, Song Y, Mo Q, Lai SY, Tweardy DJ.

Oncotarget. 2016 May 3;7(18):26307-30. doi: 10.18632/oncotarget.8368.

8.

Neuroblastoma patient outcomes, tumor differentiation, and ERK activation are correlated with expression levels of the ubiquitin ligase UBE4B.

Woodfield SE, Guo RJ, Liu Y, Major AM, Hollingsworth EF, Indiviglio S, Whittle SB, Mo Q, Bean AJ, Ittmann M, Lopez-Terrada D, Zage PE.

Genes Cancer. 2016 Jan;7(1-2):13-26.

9.

Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia.

Feng Z, Yao Y, Zhou C, Chen F, Wu F, Wei L, Liu W, Dong S, Redell M, Mo Q, Song Y.

J Hematol Oncol. 2016 Mar 12;9:24. doi: 10.1186/s13045-016-0252-7.

10.

Upregulation of EGFR signaling is correlated with tumor stroma remodeling and tumor recurrence in FGFR1-driven breast cancer.

Holdman XB, Welte T, Rajapakshe K, Pond A, Coarfa C, Mo Q, Huang S, Hilsenbeck SG, Edwards DP, Zhang X, Rosen JM.

Breast Cancer Res. 2015 Nov 18;17:141. doi: 10.1186/s13058-015-0649-1.

11.

p300 Regulates Liver Functions by Controlling p53 and C/EBP Family Proteins through Multiple Signaling Pathways.

Breaux M, Lewis K, Valanejad L, Iakova P, Chen F, Mo Q, Medrano E, Timchenko L, Timchenko N.

Mol Cell Biol. 2015 Sep 1;35(17):3005-16. doi: 10.1128/MCB.00421-15.

12.

ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors.

Shen J, Peng Y, Wei L, Zhang W, Yang L, Lan L, Kapoor P, Ju Z, Mo Q, Shih IeM, Uray IP, Wu X, Brown PH, Shen X, Mills GB, Peng G.

Cancer Discov. 2015 Jul;5(7):752-67. doi: 10.1158/2159-8290.CD-14-0849.

13.

Estimating the concordance probability in a survival analysis with a discrete number of risk groups.

Heller G, Mo Q.

Lifetime Data Anal. 2016 Apr;22(2):263-79. doi: 10.1007/s10985-015-9330-3.

PMID:
26022558
14.

CAPER is vital for energy and redox homeostasis by integrating glucose-induced mitochondrial functions via ERR-α-Gabpa and stress-induced adaptive responses via NF-κB-cMYC.

Kang YK, Putluri N, Maity S, Tsimelzon A, Ilkayeva O, Mo Q, Lonard D, Michailidis G, Sreekumar A, Newgard CB, Wang M, Tsai SY, Tsai MJ, O'Malley BW.

PLoS Genet. 2015 Apr 1;11(4):e1005116. doi: 10.1371/journal.pgen.1005116. Erratum in: PLoS Genet. 2015 Jun;11(6):e1005316.

15.

Genetic evidence that intratumoral T-cell proliferation and activation are associated with recurrence and survival in patients with resected colorectal liver metastases.

Maker AV, Ito H, Mo Q, Weisenberg E, Qin LX, Turcotte S, Maithel S, Shia J, Blumgart L, Fong Y, Jarnagin WR, DeMatteo RP, D'Angelica MI.

Cancer Immunol Res. 2015 Apr;3(4):380-8. doi: 10.1158/2326-6066.CIR-14-0212.

16.

The RNA-binding protein Rbfox1 regulates splicing required for skeletal muscle structure and function.

Pedrotti S, Giudice J, Dagnino-Acosta A, Knoblauch M, Singh RK, Hanna A, Mo Q, Hicks J, Hamilton S, Cooper TA.

Hum Mol Genet. 2015 Apr 15;24(8):2360-74. doi: 10.1093/hmg/ddv003.

17.

Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance.

Kurtova AV, Xiao J, Mo Q, Pazhanisamy S, Krasnow R, Lerner SP, Chen F, Roh TT, Lay E, Ho PL, Chan KS.

Nature. 2015 Jan 8;517(7533):209-13. doi: 10.1038/nature14034.

18.

Inhibition of histone H3K79 methylation selectively inhibits proliferation, self-renewal and metastatic potential of breast cancer.

Zhang L, Deng L, Chen F, Yao Y, Wu B, Wei L, Mo Q, Song Y.

Oncotarget. 2014 Nov 15;5(21):10665-77.

19.

SPARSE INTEGRATIVE CLUSTERING OF MULTIPLE OMICS DATA SETS.

Shen R, Wang S, Mo Q.

Ann Appl Stat. 2013 Apr 9;7(1):269-294.

20.

Genome-wide transcriptome profiling of homologous recombination DNA repair.

Peng G, Chun-Jen Lin C, Mo W, Dai H, Park YY, Kim SM, Peng Y, Mo Q, Siwko S, Hu R, Lee JS, Hennessy B, Hanash S, Mills GB, Lin SY.

Nat Commun. 2014;5:3361. doi: 10.1038/ncomms4361.

Items per page

Supplemental Content

Loading ...
Support Center